World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
44882
World Ranking
8475
National Ranking
830

Mark Emberton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark Emberton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,033 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark Emberton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Emberton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Mark Emberton is affiliated with University College London in the United Kingdom. Their research focuses primarily on the field of Medicine, with a notable emphasis on subfields such as Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Rheumatology, Surgery, and Biomedical Engineering.

The scientist's main topics of work include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Radiomics and Machine Learning in Medical Imaging
  • Urologic and Reproductive Health Conditions
  • MRI in Cancer Diagnosis
  • Bladder and Urothelial Cancer Treatments
  • Advanced Radiotherapy Techniques

Mark Emberton has contributed to several frequent publication venues, highlighting a focus on urology and oncological imaging. These venues include:

  • European Urology
  • The Journal of Urology
  • British Journal of Urology
  • European Urology Open Science
  • arXiv (Cornell University)

Their frequent co-authors reflect a collaborative network centered on urological cancer research and imaging:

  • Caroline M. Moore
  • Alex Freeman
  • Shonit Punwani
  • Hashim U. Ahmed
  • Francesco Giganti

Recent papers authored or co-authored by Mark Emberton include:

  • "Early detection of cancer," 2022, Science
  • "Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial," 2020, European Urology Oncology
  • "Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study," 2020, European Urology
  • "Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience," 2022, European Urology
  • "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now," 2020, Prostate Cancer and Prostatic Diseases

Mark Emberton has received recognition as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

    Hashim U Ahmed;Hashim U Ahmed;Ahmed El-Shater Bosaily;Ahmed El-Shater Bosaily;Louise C. Brown;Rhian Gabe

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco

  • EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

    Matthias Oelke;Alexander Bachmann;Aurélien Descazeaud;Mark Emberton

  • Systematic review of complications of prostate biopsy.

    Stacy Loeb;Annelies Vellekoop;Hashim U. Ahmed;James Catto

  • Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

    Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz

  • Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

    Jurgen J. Fütterer;Alberto Briganti;Pieter De Visschere;Mark Emberton

  • EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

    Stephan Madersbacher;Gerasimos Alivizatos;Jorgen Nordling;Carlos Rioja Sanz

  • Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

    Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton

  • Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review

    Massimo Valerio;Massimo Valerio;Massimo Valerio;Ian Donaldson;Mark Emberton;Mark Emberton;Behfar Ehdaie

  • How good is MRI at detecting and characterising cancer within the prostate

    Alexander P.S. Kirkham;Mark Emberton;Clare Allen

  • Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

    Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton

  • Weakly-supervised convolutional neural networks for multimodal image registration.

    Yipeng Hu;Yipeng Hu;Marc Modat;Eli Gibson;Wenqi Li

  • Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

    Hashim U Ahmed;Hashim U Ahmed;Richard G Hindley;Louise Dickinson;Louise Dickinson;Alex Freeman

  • Is it time to consider a role for MRI before prostate biopsy

    Hashim U. Ahmed;Alex Kirkham;Manit Arya;Rowland Illing

  • The role of focal therapy in the management of localised prostate cancer: a systematic review

    Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk

  • Photodynamic therapy for prostate cancer—a review of current status and future promise

    Caroline M Moore;Doug Pendse;Mark Emberton

  • Benign prostatic hyperplasia: A progressive disease of aging men

    Mark Emberton;Gerald L Andriole;Jean de la Rosette;Bob Djavan

  • Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

    Abdel Rahmène Azzouzi;Sébastien Vincendeau;Eric Barret;Antony Cicco

  • Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping Biopsy

    Hashim Uddin Ahmed;Yipeng Hu;Tim Carter;Nimalan Arumainayagam

  • New and Established Technology in Focal Ablation of the Prostate: A Systematic Review

    Massimo Valerio;Massimo Valerio;Massimo Valerio;Yannick Cerantola;Scott E. Eggener;Herbert Lepor

Frequent Co-Authors

Hashim U. Ahmed
Hashim U. Ahmed Imperial College Healthcare NHS Trust
Jan van der Meulen
Jan van der Meulen University of London
Dean C. Barratt
Dean C. Barratt University College London
David J. Hawkes
David J. Hawkes University College London
Chris Parker
Chris Parker Institute of Cancer Research
Arnauld Villers
Arnauld Villers University of Lille
Laurence Klotz
Laurence Klotz University of Toronto
Samir S. Taneja
Samir S. Taneja New York University
Susan A. Charman
Susan A. Charman Monash University
David Atkinson
David Atkinson University of Liverpool

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a single path. Many students interested in healthcare may find alternative or supplementary degrees and career pathways that suit their goals or lifestyle. For those who are already registered nurses and want to advance, consider earning an rn to bsn online without clinicals—an option that provides flexibility and removes the requirement of in-person clinical experience.

If you aspire to reach the highest practice levels, pursuing a Doctor of Nursing Practice (DNP) is a popular route. Many professionals seek the fastest dnp program to quickly advance their careers, while others look for more affordable dnp programs that make higher education more attainable without compromising quality.

Another viable entry point into healthcare is becoming a Licensed Practical Nurse (LPN). Those eager to join the workforce sooner may be interested in a fast lpn program, which enables students to start their careers quickly through accelerated online coursework.

With these diverse online offerings, students can find a program that matches both their career ambitions and lifestyle needs, from entry-level nursing to advanced clinical practice.

Best Scientists Citing Mark Emberton

Trending Scientists

Recently Published Articles